Review of proliferative variables and their predictive value

Affiliations

Review

R Silvestrini et al. Recent Results Cancer Res. 1993.

. 1993:127:71-6.

doi: 10.1007/978-3-642-84745-5_10.

No abstract available

Similar articles

Proliferative activity in primary breast carcinomas is a salient prognostic factor.
Michels JJ, Marnay J, Delozier T, Denoux Y, Chasle J. Michels JJ, et al. Cancer. 2004 Feb 1;100(3):455-64. doi: 10.1002/cncr.11916. Cancer. 2004. PMID: 14745860
Relationships between proliferative activity and oncogene expression in human breast cancer.
Geuna M, Palestro G, Bianchi Malandrone L, Durando A, Demurtas A, Torchio B, Massobrio M. Geuna M, et al. Ann N Y Acad Sci. 1996 Apr 30;784:555-63. doi: 10.1111/j.1749-6632.1996.tb16280.x. Ann N Y Acad Sci. 1996. PMID: 8651616 No abstract available.
[Comparison of different methods for determination of proliferative activity of breast carcinomas].
Mink D, Villena-Heinsen C, Tossounidis I, Schmidt W. Mink D, et al. Gynakol Geburtshilfliche Rundsch. 1995;35 Suppl 1:53-6. doi: 10.1159/000272564. Gynakol Geburtshilfliche Rundsch. 1995. PMID: 8672927 German.
Applicability of flow cytometry in breast cancer.
Clark GM. Clark GM. Ann N Y Acad Sci. 1993 Mar 20;677:379-83. doi: 10.1111/j.1749-6632.1993.tb38792.x. Ann N Y Acad Sci. 1993. PMID: 8494222 Review.
Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference.
Hedley DW, Clark GM, Cornelisse CJ, Killander D, Kute T, Merkel D. Hedley DW, et al. Cytometry. 1993;14(5):482-5. doi: 10.1002/cyto.990140505. Cytometry. 1993. PMID: 8354119 Review. No abstract available.